Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment.
Valvular heart disease is present in about 1% of pregnancies, and it poses a management challenge as both fetal and maternal lives are at risk of complications. Pregnancy is associated with significant hemodynamic changes, which can compromise the cardiac status in women with underlying valvular disorders. Management of valvular heart diseases has undergone considerable innovation and advancement with newer techniques, approaches and devices being employed. The decision regarding the management of anticoagulation, especially in patients with prosthetic valves, raises distinct questions and challenges. In this review, we describe the management of common valvular heart diseases encountered during pregnancy, role of percutaneous catheter based therapeutic interventions, the importance of a team-based approach, and the challenges given existing gaps in the literature.
Published In/Presented At
Gupta, R., Malik, A. H., Ranchal, P., Aronow, W. S., Vyas, A. V., Rajeswaran, Y., Quinones, J., & Ahnert, A. M. (2021). Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment. Current problems in cardiology, 46(3), 100679. https://doi.org/10.1016/j.cpcardiol.2020.100679
Cardiology | Obstetrics and Gynecology
Cardiology Division, Department of Obstetrics and Gynecology